IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q4 2021 Holdings

Filed 2022-02-14 | 14 holdings | $101.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$46.4M700,42645.9%
Arvinas Inc(ARVN)COM04335A105$46.3M563,45145.7%
Argenx SE(ARGX)SPONSORED ADR04016X101$7.8M22,2007.7%
Spdr S&P 500 ETF TR TR(SPY)PutUNIT78462F103$475.0K1,000,0000.5%
Spero Therapeutics Inc(SPRO)COM84833T103$79.5K4,964,1810.1%
Blueprint Medicines Corp(2L9)COM09627Y109$69.1K645,5390.1%
Regenxbio Inc(RGNX)COM75901B107$33.1K1,013,5960.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$33.1K1,509,9440.0%
Merus N VCOMN5749R100$28.5K896,5020.0%
Amryt Pharma PLCSPONSORED ADS03217L106$17.7K1,640,0000.0%
Uniqure NV(QURE)SHSN90064101$14.0K676,2060.0%
Magenta Therapeutics IncCOM55910K108$14.0K3,155,0820.0%
Pieris Pharmaceuticals IncCOM720795103$12.1K3,196,5270.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$5.0K127,5000.0%